Exclusive

Publication

Byline

Location

US Patent Issued to Scholar Rock on Oct. 6 for "TGFbeta1-binding immunoglobulins and use thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,226, issued on Oct. 6, was assigned to Scholar Rock Inc. (Cambridge, Mass.). "TGFbeta1-binding immunoglobulins and use thereof" was invented... Read More


US Patent Issued to Beijing Wisdomab Biotechnology, GENRIX (Shanghai) Biopharmaceutical Co.Ltd., Chongqing Genrix Biopharmaceutical on Oct. 6 for "Antibodies against human TSLP and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,227, issued on Oct. 6, was assigned to Beijing Wisdomab Biotechnology Co. Ltd. (Beijing), GENRIX (Shanghai) Biopharmaceutical Co.Ltd. (Shangh... Read More


US Patent Issued to The Trustees of Columbia University in the City of New York on Oct. 6 for "Compositions and methods for genetically-encoded high voltage-activated calcium channel blockers using engineered ubiquitin ligases" (New York, New Jersey Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,228, issued on Oct. 6, was assigned to The Trustees of Columbia University in the City of New York (New York). "Compositions and methods for... Read More


US Patent Issued to NEXTCURE on Oct. 6 for "Compositions and methods for modulating FLRT3 mediated signal transduction" (Maryland Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,229, issued on Oct. 6, was assigned to NEXTCURE INC. (Beltsville, Md.). "Compositions and methods for modulating FLRT3 mediated signal trans... Read More


US Patent Issued to SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL on Oct. 6 for "Anti-Nectin-4 antibody, conjugate including the same, and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,230, issued on Oct. 6, was assigned to SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL Co. LTD. (Chengdu, China). "Anti-Nectin-4 antibody, conjugate... Read More


US Patent Issued to BIOHENG THERAPEUTICS on Oct. 6 for "NKG2A-targeting antibody and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,231, issued on Oct. 6, was assigned to BIOHENG THERAPEUTICS Ltd. (Grand Cayman, Cayman Islands). "NKG2A-targeting antibody and use thereof" ... Read More


US Patent Issued to CHINA MEDICAL UNIVERSITY HOSPITAL on Oct. 6 for "Fusion protein comprising anti-CD3 single domain antibody, exosomal protein CD63 and RNA binding protein, and uses thereof" (Taiwanese Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,232, issued on Oct. 6, was assigned to CHINA MEDICAL UNIVERSITY HOSPITAL (Taichung City, Taiwan). "Fusion protein comprising anti-CD3 single... Read More


US Patent Issued to Orionis Biosciences, VIB VZW, UNIVERSITEIT Gent on Oct. 6 for "Methods of cancer treatment with PD-L1 targeted interferon therapeutic agents" (Belgian, American Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,233, issued on Oct. 6, was assigned to Orionis Biosciences BV (Ghent, Belgium), VIB VZW (Ghent, Belgium) and UNIVERSITEIT Gent (Ghent, Belgiu... Read More


US Patent Issued to Purdue Research Foundation on Oct. 6 for "Canine PD-L1 antibody, antigen binding fragments thereof, and methods of use thereof" (Indiana Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,234, issued on Oct. 6, was assigned to Purdue Research Foundation (West Lafayette, Ind.). "Canine PD-L1 antibody, antigen binding fragments ... Read More


US Patent Issued to TOSOH on Oct. 6 for "Fc-binding protein having improved acid stability, production method for said protein, and antibody-adsorbing agent using said protein" (Japanese Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,235, issued on Oct. 6, was assigned to TOSOH Corp. (Yamaguchi, Japan). "Fc-binding protein having improved acid stability, production method... Read More